Navigation Links
Omega Protein Comments on California Lawsuit Alleging Fish Oil Contaminants
Date:3/3/2010

HOUSTON, March 3 /PRNewswire-FirstCall/ -- Omega Protein Corporation (NYSE: OME), the nation's leading producer of Omega-3 fish oil and specialty fish meal products, is disappointed that plaintiffs in California have filed a lawsuit yesterday against eight dietary supplement brands and retailers.  The Company's products are in full compliance with all federal laws promulgated by the U.S. Food and Drug Administration, standards of the European Commission and the labeling requirements of California's Proposition 65.  In addition, the Company's products meet the rigorous standards for quality promulgated by both the Center for Responsible Nutrition (CRN) and the Global Organization for EPA and DHA Omega-3's (GOED).  

The Company has worked cooperatively with the groups behind the lawsuit in California for the past several months, sharing information and answering any questions that arose.  There are many issues on which Omega Protein disagrees with the plaintiffs, including methods of measuring PCBs, the level of PCBs at which a wa
'/>"/>

SOURCE Omega Protein Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Purity Products Releases Their Next Generation Lycopene Omega-3 Super Formula
2. Omega-3 Supplements Dont Reduce Risk of Preterm Birth
3. Shedding Light on Why Omega-3 Fatty Acids May Help the Heart
4. CapitalSource Closes First Step of Long-Term Care Facility Sale to Omega Healthcare Investors
5. Could Omega-3s Boost Blood Fat Levels?
6. New study links DHA type of omega-3 to better nervous-system function
7. Selenium, Omega-3s May Stave Off Colorectal Cancer
8. Nordic Naturals Ultimate Omega(TM) First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program
9. Biotech Soybeans Good Source of Omega-3
10. Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health
11. Nordic Naturals Professional Exclusive Division Introduces Prenatal DHA An Omega-3 Fatty Acid Supplement for Pregnant Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Tampa, Florida (PRWEB) June 03, 2015 ... mobile friendly website yesterday, to make shopping for health ... The improved website has a fresh look and makes ... for medical centers around you. , Now, when ... prices for radiology and surgical procedures) they can see ...
(Date:6/3/2015)... 03, 2015 The Canton Group, a ... with technology, announced today that Tim Dodge has joined ... joins The Canton Group as it implements ... customer engagements. , Tim is a tech industry veteran ... variety of technology companies. Before joining The Canton Group, ...
(Date:6/3/2015)... 03, 2015 Follow us on ... has revolutionized disease treatment on account of their better ... diseases, such as rheumatoid arthritis. The industry is expected ... traditional small molecule drugs to biopharmaceuticals over the coming ... cell and gene therapies, and recombinant proteins has attracted ...
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... Seattle, WA (PRWEB) June 03, 2015 ... health insurance exchange technology, has announced that CEO Jonathan ... (AHIP) Institute 2015 on June 4, 2015. The ... and digital technologies are disrupting traditional business models in ... new business value. , WHAT: Digital Transformation and ...
Breaking Medicine News(10 mins):Health News:Save On Medical Launches New Mobile-Optimized Website 2Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2
... pair of new vaccines that not only fight cocaine and ... ,The study was conducted by a team of researchers ... Baylor College of Medicine (BCM). ,As part of ... subjects administered to it. ,Researchers found that study ...
... has shown a decline, thanks to the comprehensive program in ... the 2006 report shows a decline in the smoking ... the past year, smoking decreased among men (from 22.5% to ... declines followed a year-long ad campaign aimed at prompting more ...
... and even dabbled with French, but it was only when ... was established. ,Georgia has an IQ of ... Mensa. ,The youngest daughter of a chief executive and ... on intelligent children as the brightest two-year-old she has ever ...
... GmbH presented the first clinical evidence for the ... for patients suffering from chronic pain at ... Rheumatism (EULAR), 13-16 June 2007, Barcelona, Spain. Tapentadol, ... its kind, combining two analgesic principles, mu-receptor agonism ...
... university researchers has found a new modified drug for Alzheimers ... trials. ,Millions of people suffer from this ... Ghosh, the Purdue professor who led the creation of the ... be the first disease-modifying therapy. It may be able to ...
... Organization (WHO) based Special Programme for Research and ... new strategy for strengthening and expanding research ... ,The strategy builds on the programmes ... and enhancing research capacity in countries where parasitic ...
Cached Medicine News:Health News:New York Records Decline in Smoking Rate 2Health News:Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius 2Health News:Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment 2Health News:Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment 3Health News:Modified Drug Therapy for Alzheimers Disease 2
(Date:6/3/2015)... 2015  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ... immunotherapies, today announced that it has entered into ... purchase approximately $13.6 million of securities in a ... to such investors an aggregate of 2,469,091 shares ... $5.50 per share. The gross ...
(Date:6/3/2015)... Saudi Arabia , June 3, 2015  Varian Medical Systems ... software for the treatment of cancer, is expanding in the ... strategic operating entity in Saudi Arabia . ... with El Seif Development Group, was officially launched today at ... officer Dow Wilson. "This move represents the ...
(Date:6/3/2015)... , June 3, 2015  Lightlake Therapeutics ... addiction treatments based on its expertise in opioid ... Lightlake,s partner for treating opioid overdose with intranasal ... New Drug Application (NDA) to the United States ... spray formulation of naloxone, a drug intended to ...
Breaking Medicine Technology:OncoSec Medical Announces $13.6 Million Registered Direct Offering 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 3Varian Establishes Local Entity in Saudi Arabia to Support Expansion in Middle East 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3
... ANGELES, April 28, 2011 This afternoon, at ... Florida, ( http://www.epilepsy.com/etp/aedtrialxi ) Dr. Christopher DeGiorgio, principal ... of a Phase II randomized double-blind clinical trial ... study was conducted at UCLA and the University ...
... DIEGO, April 28, 2011 ResMed Inc. (NYSE: ... quarter ended March 31, 2011.  Revenue for the quarter ended ... a 12% increase on a constant currency basis) over the ... 31, 2011, income from operations was $64.0 million and net ...
Cached Medicine Technology:Positive Results Reported for Phase II Randomized Double-Blind Clinical Trial for the Treatment of Drug-Resistant Epilepsy Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 2Positive Results Reported for Phase II Randomized Double-Blind Clinical Trial for the Treatment of Drug-Resistant Epilepsy Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 3Positive Results Reported for Phase II Randomized Double-Blind Clinical Trial for the Treatment of Drug-Resistant Epilepsy Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 4ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 2ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 3ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 4ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 5ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 6
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: